PREDICTIVE VALUE OF CD24 AND CD44 FOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND PROGNOSIS IN PATIENTS WITH PRIMARY BREAST CANCER

被引：0
|
作者：
Horiguchi, K. [1 ,8 ]
Toi, M. [2 ]
Horiguchi, S. [3 ,8 ]
Sugimoto, M. [5 ,6 ]
Naito, Y. [4 ,5 ,6 ]
Hayashi, Y. [3 ]
Ueno, T. [2 ]
Ohno, S. [7 ]
Sekine, S. [1 ]
Kitagawa, D. [1 ]
Aruga, T. [1 ]
Suzuki, E. [1 ]
Yamashita, T. [1 ]
Funata, N. [3 ]
Tomita, M. [4 ,5 ,6 ]
Eishi, Y. [8 ]
Kuroi, K. [1 ]
机构：
[1] Metropolitan Komagome Hosp, Dept Surg, Canc & Infect Dis Ctr Tokyo, Tokyo, Japan
[2] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan
[3] Metropolitan Komagome Hosp, Dept Pathol, Canc & Infect Dis Ctr Tokyo, Tokyo, Japan
[4] Keio Univ, Inst Adv Biosci, Kanagawa, Japan
[5] Keio Univ, Syst Biol Program, Grad Sch Media & Governance, Kanagawa, Japan
[6] Keio Univ, Dept Environm & Informat Studies, Kanagawa, Japan
[7] Natl Hosp Org Kyusyu Canc Ctr, Dept Breast Oncol, Fukuoka, Japan
[8] Tokyo Med & Dent Univ, Dept Human Pathol, Grad Sch, Tokyo, Japan
来源：
EJC SUPPLEMENTS | 2011年 / 9卷 / 01期
关键词：
D O I：
10.1016/j.ejcsup.2011.02.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [31] CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
    Moon, Yong Wha
    An, Hee-Jung
    Koo, Ja Seung
    Kim, Gun Min
    Han, Hyunju
    Park, Seho
    Kim, Seung Il
    Park, Hyung Seok
    Kim, Sewha
    Kim, Seung Ki
    Lee, Seung Ah
    Hwang, Sohyun
    Son, Gun Woo
    Sohn, Joohyuk
    [J]. ONCOTARGET, 2018, 9 (02) : 2622 - 2630
  • [32] CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
    Xueyuan Cao
    Donghui Cao
    MeiShan Jin
    Zhifang Jia
    Fei Kong
    Hongxi Ma
    Yinping Wang
    Jing Jiang
    [J]. BMC Gastroenterology, 14
  • [33] CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
    Cao, Xueyuan
    Cao, Donghui
    Jin, MeiShan
    Jia, Zhifang
    Kong, Fei
    Ma, Hongxi
    Wang, Yinping
    Jiang, Jing
    [J]. BMC GASTROENTEROLOGY, 2014, 14
  • [34] Utility of CD44/CD24 in the Outcome and Prognosis of Oral Squamous Cell Carcinoma: A Systematic Review
    Krishnan, Reshma Poothakulath
    Pandiar, Deepak
    Ramani, Pratibha
    Ramalingam, Karthikeyan
    Jayaraman, Selvaraj
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [35] Predictive Value of CD44, CD24, CD133 and P-glycoprotein for Response to Treatment With a Pan ErbB Blocker and Gemcitabine in Pancreatic Tumour Cells
    Ioannou, N.
    Seddon, A. M.
    Dalgleish, A. G.
    Mackintosh, D.
    Modjtahedi, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S99 - S99
  • [36] Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
    de Beca, Francisco Ferro
    Caetano, Pedro
    Gerhard, Rene
    Alvarenga, Cesar Augusto
    Gomes, Madalena
    Paredes, Joana
    Schmitt, Fernando
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (03) : 187 - 191
  • [37] Association of CD44 and CD24 phenotype with lymph node metastasis and survival in triple-negative breast cancer
    Zou, Weiyan
    Yang, Yan
    Zheng, Rongsheng
    Wang, Zishu
    Zeng, Huihui
    Chen, Zhelong
    Yang, Fen
    Wang, Junbin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (05): : 1008 - 1016
  • [38] Do stem cell markers have significant implication in breast cancer? Immunohistochemical study for CD44 and CD24
    Kim, H. J.
    Kim, M. J.
    Ahn, S. H.
    Son, B. H.
    Kim, S. B.
    Jung, K. H.
    Ahn, J. H.
    Kim, H. H.
    Gong, G. Y.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 317S - 318S
  • [39] Immunophenotyping analysis in invasive micropapillary carcinoma of the breast: Role of CD24 and CD44 isoforms expression
    Simonetti, Sara
    Terracciano, Luigi
    Zlobec, Inti
    Kilic, Ergin
    Stasio, Loredana
    Quarto, Maria
    Pettinato, Guido
    Insabato, Luigi
    [J]. BREAST, 2012, 21 (02): : 165 - 170
  • [40] CD24 polymorphisms in breast cancer: impact on prognosis and risk
    Katharina Buck
    Sarah Hug
    Petra Seibold
    Irmgard Ferschke
    Peter Altevogt
    Christof Sohn
    Andreas Schneeweiss
    Barbara Burwinkel
    Dirk Jäger
    Dieter Flesch-Janys
    Jenny Chang-Claude
    Frederik Marmé
    [J]. Breast Cancer Research and Treatment, 2013, 137 : 927 - 937
12345